(Q51805408)

12 April 2018

title

Acute pulmonary edema due to rosiglitazone use in a patient with diabetes mellitus. (English)

1 reference

12 April 2018

1 reference

1 reference

Nedim Cekmen

1

1 reference

12 April 2018

Mustafa Cesur

2

1 reference

12 April 2018

Riza Cetinbas

3

1 reference

12 April 2018

Pasa Bedel

4

1 reference

12 April 2018

Ozcan Erdemli

5

1 reference

12 April 2018

publication date

1 January 2006

1 reference

12 April 2018

Journal of Intensive Care Medicine

published in

1 reference

12 April 2018

volume

21

1 reference

12 April 2018

issue

1

1 reference

12 April 2018

page(s)

47-50

1 reference

12 April 2018

https://api.crossref.org/works/10.1177%2F0885066605283385

1 reference

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Glitazones and the management of insulin resistance: what they do and how might they be used

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Management of rosiglitazone-induced edema: two case reports and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Thiazolidinedione-induced edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Unilateral edema due to a thiazolidinedione

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Thiazolidinedione-associated congestive heart failure and pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Thiazolidinedione-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Rosiglitazone plus metformin: combination therapy for Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Rosiglitazone and heart failure: long-term vigilance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

Glitazones and heart failure: critical appraisal for the clinician.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066605283385

21 January 2018

Identifiers

DOI

10.1177/0885066605283385

1 reference

12 April 2018

1 reference

12 April 2018